From: Survival and quality of life after surgical aortic valve replacement in octogenarians
Age < 80 | Age ≥ 80 | |||
---|---|---|---|---|
N = 597 | N = 163 | P | ||
Male sex | 363 (60.8) | 85 (52.1) | 0.057 | |
Age, years | 71 (66–75) | 82 (81–83) | <0.001 | |
History of: | ||||
DM | 145 (24.4) | 37 (22.7) | 0.727 | |
Hypertension | 325 (54.4) | 98 (60.1) | 0.228 | |
COPD | 116 (19.4) | 30 (18.4) | 0.855 | |
Peripheral VD | 70 (11.7) | 17 (10.4) | 0.748 | |
Stroke | 66 (11.1) | 20 (12.3) | 0.768 | |
MI | 74 (12.4) | 21 (12.9) | 0.979 | |
PCI | 65 (10.9) | 18 (11.0) | 1.000 | |
Cardiac surgery | 42 (7.0) | 8 (4.9) | 0.428 | |
Creatinine (mmol/L) | 88 (75–104) | 92 (77–110) | 0.001 | |
EuroSCORE | 6 (5–7) | 8 (8–10) | <0.001 | |
Log EuroSCORE | 4.9 (3.1–7.6) | 10.7 (8.4–15.7) | <0.001 | |
LVEF | >50 % | 468 (78.7) | 113 (69.3) | 0.044 |
30–50 % | 103 (17.3) | 40 (24.5) | ||
<30 % | 24 (4.0) | 10 (6.1) | ||
NYHA | Class 1 | 145 (24.3) | 45 (27.6) | 0.149 |
Class 2 | 342 (57.4) | 80 (49.1) | ||
Class 3 | 109 (18.3) | 38 (23.3) | ||
Peak gradient AV (mmHg) | 73 (60–90) | 71 (58–88) | 0.55 | |
Operative characteristics | ||||
Bioprosthesis | 541 (90.6) | 159 (97.6) | <0.001 | |
CABG | 298 (49.9) | 75 (46.0) | 0.426 | |
X-clamp time (min) | 91 (75–111) | 82 (68–107) | 0.004 |